Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) currently has a daily average trading volume of 4.58M but it saw 2843540 shares traded in last market. With a market cap of 410.40M USD, the company’s current market price of $1.13 came falling about -6.61 while comparing to the previous closing price of $1.21. In past 52 weeks, the stock remained buoying in the range of price level as high as $2.45 and as low as $0.28. In the recent trading on the day, stock has struck highest price mark of $1.12 while lowest mark touched by it was $1.24.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Leerink Partners which downgraded the stock as “Market Perform” in its note to investors issued on March 05, 2025, recommending a price target of between $2 and $1 for it. Leerink Partners issued its recommendations for the stock as it initiated the price target for the stock is $5.
Over the week, LXRX’s stock price is moving -16.30% down while it is 46.70% when we observe its performance for the past one month. Year-to-date it is -43.22% down and over the past year, the stock is showing an upside performance of 53.01%.
Currently, Lexicon Pharmaceuticals Inc’s total number of outstanding shares is 363.18M with 1.17% of that held by the insiders while 76.53% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -95.22% and return on equity (ROE) at -86.09%. Stock’s beta reads 1.19. Stock has a price to book (P/B) ratio of 3.34 while price to sale or P/S ratio amounts to 13.15. Its return on asset (ROA) is -49.60% on average.
